Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors

被引:309
作者
Nioi, P [1 ]
Hayes, JD [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
基金
英国医学研究理事会;
关键词
NAD(P)H : quinone oxidoreductase 1; antioxidant response element; Nrf2; small Maf protein; cancer chemoprevention; xenobiotic response element; Ah receptor; sulforaphane; butylated hydroxyanisole;
D O I
10.1016/j.mrfmmm.2004.05.023
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
NAD(P)H:quinone oxidoreductase I (NQOI) is a key enzyme involved in defence against reactive forms of oxygen and inhibition of neoplasia. Under conditions of oxidative stress, expression of NQO1 is induced, and the resulting increase in oxidoreductase protein provides the cell with multiple layers of protection against environmental insults. Firstly, the catalytic activity of NQO1 is directed towards the complete reduction and detoxication of highly reactive quinones. Secondly, the oxidoreductase maintains the endogenous lipid-soluble antioxidants, alpha-tocopherol-hydroquinone and ubiquinol in their reduced and active forms. Thirdly, NQO1 is required for the stabilisation of p53 protein in response to DNA-damaging stimuli, and it thereby influences cell fate decisions. In view of the anticarcinogenic actions of NQO1, an understanding of the mechanisms that govern its expression is desirable. The redox sensitivity of NQO1 transcription occurs through a cis-acting antioxidant response element (ARE) located within the regulatory region of the mouse, rat and human genes. This element recruits the positively acting basic leucine zipper (bZip) transcription factor NF-E2 p45-related factor 2 (Nrf2). Under normal constitutive conditions, Nrf2 associates with the cytoskeletal-binding protein Keap1, which regulates the subcellular distribution of the bZip factor and also targets it for proteasome-dependent degradation. Oxidative stress inhibits the Nrf2-Keap1 interaction, thus promoting nuclear accumulation of the transcription factor and transactivation of NQO1 and other ARE-driven genes. Mouse, rat and human NQO1 can also be induced by planar aromatic hydrocarbons through a cis-acting xenobiotic response element (XRE) located in their gene promoters. The XRE recruits the ary1hydrocarbon receptor (AhR) and AhR nuclear translocator. Cross-talk may occur between Nrf2 and AhR, but the details of this process remain to be elucidated. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 171
页数:23
相关论文
共 151 条
[1]  
Alam J, 2000, J BIOL CHEM, V275, P27694
[2]   Interaction of human NAD(P)H:Quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems [J].
Anwar, A ;
Dehn, D ;
Siegel, D ;
Kepa, JK ;
Tang, LJ ;
Pietenpol, JA ;
Ross, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) :10368-10373
[3]   NQ01 stabilizes p53 through a distinct pathway [J].
Asher, G ;
Lotem, J ;
Kama, R ;
Sachs, L ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3099-3104
[4]   Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase-1 [J].
Asher, G ;
Lotem, J ;
Cohen, B ;
Sachs, L ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) :1188-1193
[5]  
Asher G, 2004, METHOD ENZYMOL, V382, P278
[6]   p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1 [J].
Asher, G ;
Lotem, J ;
Tsvetkov, P ;
Reiss, V ;
Sachs, L ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15065-15070
[7]   Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQ01 [J].
Asher, G ;
Lotem, J ;
Sachs, L ;
Kahana, C ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13125-13130
[8]  
ASMAN DC, 1993, J BIOL CHEM, V268, P12530
[9]   Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours:: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy [J].
Basu, S ;
Brown, JE ;
Flannigan, GM ;
Gill, JH ;
Loadman, PM ;
Martin, SW ;
Naylor, B ;
Scally, AJ ;
Seargent, JM ;
Shah, T ;
Puri, R ;
Phillips, RM .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (05) :703-709
[10]  
Begleiter A, 2004, METHOD ENZYMOL, V382, P320